Previous studies have found lower mortality and renal failure in patients with SBP given IV albumin, but it is unclear if all patients benefit. This retrospective analysis found no benefit of albumin in those at low risk (bun<11 and bilirubin <~4 mg/dL), but did find a benefit in those at high risk (bun>11 or bilirubin >~4 mg/dL). Albumin should not be given to SBP patients with normal BUN and bilirubin (abstract)
Share This Post
Categories
Related Posts
Do you have a stack of journals piling up on your desk, beside your bed or in your email inbox? In 1950, medical knowledge was estimated to double every 50 years, but now the doubling time is every few months. At this rate, it is impossible to keep up with the literature, but a group […]
This large systematic review found rectal NSAIDs significantly reduced the risk of post-ERCP pancreatitis compared to pancreatic duct stents (abstract).
This large population-based cohort found the most common causes of drug induced liver injury to be augmentin and diclofenac, followed by herbal and nutritional supplements (abstract).
Leave A Comment